157 related articles for article (PubMed ID: 37882064)
1. A SNAI2/CTCF Interaction is Required for
Sreenivas P; Wang L; Wang M; Challa A; Modi P; Hensch NR; Gryder B; Chou HC; Zhao XR; Sunkel B; Moreno-Campos R; Khan J; Stanton BZ; Ignatius MS
Mol Cell Biol; 2023; 43(11):547-565. PubMed ID: 37882064
[TBL] [Abstract][Full Text] [Related]
2. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative Rhabdomyosarcoma.
Hensch NR; Bondra K; Wang L; Sreenivas P; Zhao XR; Modi P; Vaseva AV; Houghton PJ; Ignatius MS
Mol Cancer Ther; 2023 Jan; 22(1):123-134. PubMed ID: 36162055
[TBL] [Abstract][Full Text] [Related]
4. SNAI2-Mediated Repression of
Wang L; Hensch NR; Bondra K; Sreenivas P; Zhao XR; Chen J; Moreno Campos R; Baxi K; Vaseva AV; Sunkel BD; Gryder BE; Pomella S; Stanton BZ; Zheng S; Chen EY; Rota R; Khan J; Houghton PJ; Ignatius MS
Cancer Res; 2021 Nov; 81(21):5451-5463. PubMed ID: 34462275
[TBL] [Abstract][Full Text] [Related]
5. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
[TBL] [Abstract][Full Text] [Related]
6. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
Khoury A; Achinger-Kawecka J; Bert SA; Smith GC; French HJ; Luu PL; Peters TJ; Du Q; Parry AJ; Valdes-Mora F; Taberlay PC; Stirzaker C; Statham AL; Clark SJ
Nat Commun; 2020 Jan; 11(1):54. PubMed ID: 31911579
[TBL] [Abstract][Full Text] [Related]
7. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
Kang J; Kim YW; Park S; Kang Y; Kim A
FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
[TBL] [Abstract][Full Text] [Related]
9. CTCF modulates allele-specific sub-TAD organization and imprinted gene activity at the mouse Dlk1-Dio3 and Igf2-H19 domains.
Llères D; Moindrot B; Pathak R; Piras V; Matelot M; Pignard B; Marchand A; Poncelet M; Perrin A; Tellier V; Feil R; Noordermeer D
Genome Biol; 2019 Dec; 20(1):272. PubMed ID: 31831055
[TBL] [Abstract][Full Text] [Related]
10. The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract][Full Text] [Related]
11. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
[TBL] [Abstract][Full Text] [Related]
12. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
[TBL] [Abstract][Full Text] [Related]
13. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
Kim J; Kang J; Kim YW; Kim A
FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
[TBL] [Abstract][Full Text] [Related]
14. Active enhancers strengthen insulation by RNA-mediated CTCF binding at chromatin domain boundaries.
Islam Z; Saravanan B; Walavalkar K; Farooq U; Singh AK; Radhakrishnan S; Thakur J; Pandit A; Henikoff S; Notani D
Genome Res; 2023 Jan; 33(1):1-17. PubMed ID: 36650052
[TBL] [Abstract][Full Text] [Related]
15. Control of directionality of chromatin folding for the inter- and intra-domain contacts at the Tfap2c-Bmp7 locus.
Tsujimura T; Takase O; Yoshikawa M; Sano E; Hayashi M; Takato T; Toyoda A; Okano H; Hishikawa K
Epigenetics Chromatin; 2018 Sep; 11(1):51. PubMed ID: 30213272
[TBL] [Abstract][Full Text] [Related]
16. Local chromatin interactions contribute to expression of the fibrinogen gene cluster.
Espitia Jaimes C; Fish RJ; Neerman-Arbez M
J Thromb Haemost; 2018 Oct; 16(10):2070-2082. PubMed ID: 30039577
[TBL] [Abstract][Full Text] [Related]
17. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation.
Fang C; Wang Z; Han C; Safgren SL; Helmin KA; Adelman ER; Serafin V; Basso G; Eagen KP; Gaspar-Maia A; Figueroa ME; Singer BD; Ratan A; Ntziachristos P; Zang C
Genome Biol; 2020 Sep; 21(1):247. PubMed ID: 32933554
[TBL] [Abstract][Full Text] [Related]
18. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
19. Key role for CTCF in establishing chromatin structure in human embryos.
Chen X; Ke Y; Wu K; Zhao H; Sun Y; Gao L; Liu Z; Zhang J; Tao W; Hou Z; Liu H; Liu J; Chen ZJ
Nature; 2019 Dec; 576(7786):306-310. PubMed ID: 31801998
[TBL] [Abstract][Full Text] [Related]
20. CTCF boundary remodels chromatin domain and drives aberrant
Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
